These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 34503244)

  • 1. Targeting PI3K Pathway in Pancreatic Ductal Adenocarcinoma: Rationale and Progress.
    Mehra S; Deshpande N; Nagathihalli N
    Cancers (Basel); 2021 Sep; 13(17):. PubMed ID: 34503244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphoinositide 3-Kinase Signaling Pathway in Pancreatic Ductal Adenocarcinoma Progression, Pathogenesis, and Therapeutics.
    Murthy D; Attri KS; Singh PK
    Front Physiol; 2018; 9():335. PubMed ID: 29670543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16.
    Chalabi-Dchar M; Cassant-Sourdy S; Duluc C; Fanjul M; Lulka H; Samain R; Roche C; Breibach F; Delisle MB; Poupot M; Dufresne M; Shimaoka T; Yonehara S; Mathonnet M; Pyronnet S; Bousquet C
    Gastroenterology; 2015 Jun; 148(7):1452-65. PubMed ID: 25683115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.
    Totiger TM; Srinivasan S; Jala VR; Lamichhane P; Dosch AR; Gaidarski AA; Joshi C; Rangappa S; Castellanos J; Vemula PK; Chen X; Kwon D; Kashikar N; VanSaun M; Merchant NB; Nagathihalli NS
    Mol Cancer Ther; 2019 Feb; 18(2):301-311. PubMed ID: 30404927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upstream and Downstream Co-inhibition of Mitogen-Activated Protein Kinase and PI3K/Akt/mTOR Pathways in Pancreatic Ductal Adenocarcinoma.
    Wong MH; Xue A; Baxter RC; Pavlakis N; Smith RC
    Neoplasia; 2016 Jul; 18(7):425-35. PubMed ID: 27435925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCL26 is upregulated by nab-paclitaxel in pancreatic cancer-associated fibroblasts and promotes PDAC invasiveness through activation of the PI3K/AKT/mTOR pathway.
    Chen X; An Y; Zhang Y; Xu D; Chen T; Yang Y; Chen W; Wu D; Zhang X
    Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):612-619. PubMed ID: 33764366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models.
    Jiang H; Xu M; Li L; Grierson P; Dodhiawala P; Highkin M; Zhang D; Li Q; Wang-Gillam A; Lim KH
    Mol Cancer Ther; 2018 Oct; 17(10):2144-2155. PubMed ID: 30065098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting the Akt/PI3K Signaling Pathway as a Potential Therapeutic Strategy for the Treatment of Pancreatic Cancer.
    Ebrahimi S; Hosseini M; Shahidsales S; Maftouh M; Ferns GA; Ghayour-Mobarhan M; Hassanian SM; Avan A
    Curr Med Chem; 2017; 24(13):1321-1331. PubMed ID: 28176634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Upregulation of KLK8 Predicts Poor Prognosis in Pancreatic Cancer.
    Hua Q; Li T; Liu Y; Shen X; Zhu X; Xu P
    Front Oncol; 2021; 11():624837. PubMed ID: 34395235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of bone morphogenetic protein receptor 2 suppresses pancreatic ductal adenocarcinoma growth by regulating GRB2/PI3K/AKT axis.
    Wang Y; Guo H; Zhang Z; Wang Q; Tian X; Yang Y
    Ann Transl Med; 2021 Apr; 9(7):557. PubMed ID: 33987255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inverse Correlation of STAT3 and MEK Signaling Mediates Resistance to RAS Pathway Inhibition in Pancreatic Cancer.
    Nagathihalli NS; Castellanos JA; Lamichhane P; Messaggio F; Shi C; Dai X; Rai P; Chen X; VanSaun MN; Merchant NB
    Cancer Res; 2018 Nov; 78(21):6235-6246. PubMed ID: 30154150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential of PI3K/AKT/mTOR Pathway in Gastrointestinal Stromal Tumors: Rationale and Progress.
    Duan Y; Haybaeck J; Yang Z
    Cancers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells.
    Reichert M; Saur D; Hamacher R; Schmid RM; Schneider G
    Cancer Res; 2007 May; 67(9):4149-56. PubMed ID: 17483325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoglycerate Mutase 1 (PGAM1) Promotes Pancreatic Ductal Adenocarcinoma (PDAC) Metastasis by Acting as a Novel Downstream Target of the PI3K/Akt/mTOR Pathway.
    Liu X; Tan X; Liu P; Wu Y; Qian S; Zhang X
    Oncol Res; 2018 Aug; 26(7):1123-1131. PubMed ID: 29386088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The E3 ubiquitin ligase NEDD4 is translationally upregulated and facilitates pancreatic cancer.
    Weng M; Luo ZL; Wu XL; Zeng WZ
    Oncotarget; 2017 Mar; 8(12):20288-20296. PubMed ID: 28423617
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of plakoglobin is associated with upregulated MAPK and PI3K/AKT signalling pathways in early resectable pancreatic ductal adenocarcinoma.
    Nweke E; Ntwasa M; Brand M; Devar J; Smith M; Candy G
    Oncol Lett; 2020 Jun; 19(6):4133-4141. PubMed ID: 32382352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allosteric modulation of Ras and the PI3K/AKT/mTOR pathway: emerging therapeutic opportunities.
    Hubbard PA; Moody CL; Murali R
    Front Physiol; 2014; 5():478. PubMed ID: 25566081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A LETM2-Regulated PI3K-Akt Signaling Axis Reveals a Prognostic and Therapeutic Target in Pancreatic Cancer.
    Zhou S; Zhong Z; Lu Y; Li Y; Yao H; Zhao Y; Guo T; Yang K; Li Y; Chen S; Huang K; Lian G
    Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four potential microRNAs affect the progression of pancreatic ductal adenocarcinoma by targeting MET via the PI3K/AKT signaling pathway.
    Yao LC; Jiang XH; Yan SS; Wang W; Wu L; Zhai LL; Xiang F; Ji T; Ye L; Tang ZG
    Oncol Lett; 2021 Apr; 21(4):326. PubMed ID: 33692858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The hepatitis B virus X protein promotes pancreatic cancer through modulation of the PI3K/AKT signaling pathway.
    Chen Y; Bai X; Zhang Q; Wen L; Su W; Fu Q; Sun X; Lou Y; Yang J; Zhang J; Chen Q; Wang J; Liang T
    Cancer Lett; 2016 Sep; 380(1):98-105. PubMed ID: 27339327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.